Evidence map›Paper›PMID 38026959›Full record

ArticleFrontiers in pharmacology2023

Suppression of inflammation-induced lung cancer cells proliferation and metastasis by exiguaflavanone A and exiguaflavanone B from

Punnida Arjsri, Kamonwan Srisawad, Warathit Semmarath, Sonthaya Umsumarng, Lapamas Rueankham, Aroonchai Saiai, Methee Rungrojsakul, Trinnakorn Katekunlaphan, Songyot Anuchapreeda, Pornngarm Dejkriengkraikul

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Punnida ArjsriDepartment of Biochemistry, Faculty Medicine, Chiang Mai University, Chiang Mai, Thailand.
Kamonwan SrisawadDepartment of Biochemistry, Faculty Medicine, Chiang Mai University, Chiang Mai, Thailand.
Warathit SemmarathDepartment of Biochemistry, Faculty Medicine, Chiang Mai University, Chiang Mai, Thailand.
Sonthaya UmsumarngCenter for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai, Thailand.
Lapamas RueankhamDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
Aroonchai SaiaiDepartment of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand.
Methee RungrojsakulDepartment of Traditional Chinese Medicine, Faculty of Science, Chandrakasem Rajabhat University, Bangkok, Thailand.
Trinnakorn KatekunlaphanDepartment of Chemistry, Faculty of Science, Chandrakasem Rajabhat University, Bangkok, Thailand.
Songyot AnuchapreedaDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
Pornngarm DejkriengkraikulDepartment of Biochemistry, Faculty Medicine, Chiang Mai University, Chiang Mai, Thailand.
Chiang Mai University · THChandrakasem Rajabhat University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer progression and metastasisexiguaflavanoneNLRP3 inflammasome pathwaynon-small cell lung cancerSophora exigua

Identifiers

PMID38026959
PMCPMC10667455
OpenAlexW4388633725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.